These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23345234)

  • 1. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.
    Anastasio NC; Gilbertson SR; Bubar MJ; Agarkov A; Stutz SJ; Jeng Y; Bremer NM; Smith TD; Fox RG; Swinford SE; Seitz PK; Charendoff MN; Craft JW; Laezza FM; Watson CS; Briggs JM; Cunningham KA
    J Neurosci; 2013 Jan; 33(4):1615-30. PubMed ID: 23345234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats.
    Wang Y; Wang D; Chen Y; Fang X; Yu L; Zhang C
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):481-490. PubMed ID: 32710540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction.
    Müller CP; Carey RJ
    Trends Pharmacol Sci; 2006 Sep; 27(9):455-8. PubMed ID: 16876260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse.
    Ji SP; Zhang Y; Van Cleemput J; Jiang W; Liao M; Li L; Wan Q; Backstrom JR; Zhang X
    Nat Med; 2006 Mar; 12(3):324-9. PubMed ID: 16474401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.
    Anastasio NC; Lanfranco MF; Bubar MJ; Seitz PK; Stutz SJ; McGinnis AG; Watson CS; Cunningham KA
    J Neurochem; 2010 Jun; 113(6):1504-15. PubMed ID: 20345755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN-5-HT2C coupling: a new target for treating drug addiction.
    Maillet JC; Zhang Y; Li X; Zhang X
    Prog Brain Res; 2008; 172():407-20. PubMed ID: 18772044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins.
    Bécamel C; Gavarini S; Chanrion B; Alonso G; Galéotti N; Dumuis A; Bockaert J; Marin P
    J Biol Chem; 2004 May; 279(19):20257-66. PubMed ID: 14988405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells.
    Chang M; Zhang L; Tam JP; Sanders-Bush E
    J Biol Chem; 2000 Mar; 275(10):7021-9. PubMed ID: 10702266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.
    Lam DD; Przydzial MJ; Ridley SH; Yeo GS; Rochford JJ; O'Rahilly S; Heisler LK
    Endocrinology; 2008 Mar; 149(3):1323-8. PubMed ID: 18039773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between CHL1 and serotonin receptor 2c regulates signal transduction and behavior in mice.
    Kleene R; Chaudhary H; Karl N; Katic J; Kotarska A; Guitart K; Loers G; Schachner M
    J Cell Sci; 2015 Dec; 128(24):4642-52. PubMed ID: 26527397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.
    Herrick-Davis K; Grinde E; Lindsley T; Cowan A; Mazurkiewicz JE
    J Biol Chem; 2012 Jul; 287(28):23604-14. PubMed ID: 22593582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling.
    Labasque M; Reiter E; Becamel C; Bockaert J; Marin P
    Mol Biol Cell; 2008 Nov; 19(11):4640-50. PubMed ID: 18768750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor.
    Wang H; Huang Z; Huang L; Niu S; Rao X; Xu J; Kong H; Yang J; Yang C; Wu D; Li S; Li XJ; Liu T; Sheng G
    J Biol Chem; 2012 Jan; 287(3):2237-46. PubMed ID: 22123816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues.
    Cunningham KA; Fox RG; Anastasio NC; Bubar MJ; Stutz SJ; Moeller FG; Gilbertson SR; Rosenzweig-Lipson S
    Neuropharmacology; 2011 Sep; 61(3):513-23. PubMed ID: 21575646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior.
    Heisler LK; Zhou L; Bajwa P; Hsu J; Tecott LH
    Genes Brain Behav; 2007 Jul; 6(5):491-6. PubMed ID: 17451451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.